limertinib
Small moleculeexperimental
Clinical trial activity
8 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
6
Phase 3
2
Phase 4
0
Earliest trial started Nov 30, 2017 (NCT03502850)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07001995 | Phase 2 | Oct 1, 2025 | Central South University |
| NCT07109531 | Phase 3 | Aug 31, 2025 | Jiangsu Aosaikang Pharmaceutical Co., Ltd. |
| NCT07038460 | Phase 2 | Jul 31, 2025 | Shantou University |
| NCT06982924 | Phase 2 | Jun 30, 2025 | Innovent Biologics (Suzhou) Co. Ltd., Jiao Tong University |
| NCT05631678 | Phase 1 | Jun 6, 2022 | Jiangsu Aosaikang Pharmaceutical Co., Ltd. |
| NCT04360915 | Phase 1 | Dec 9, 2019 | Jiangsu Aosaikang Pharmaceutical Co., Ltd., Zhejiang University |
| NCT04143607 | Phase 3 | Jul 23, 2019 | Jiangsu Aosaikang Pharmaceutical Co., Ltd. |
| NCT03502850 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2017 | Jiangsu Aosaikang Pharmaceutical Co., Ltd. |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Aosaikang Pharmaceutical Co., Ltd. | For profit | 5 | 5 | 3 | 2017 |
| Central South University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Innovent Biologics (Suzhou) Co. Ltd. | For profit | 1 | 0 | 1 | 2025 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Shantou University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2019 |
6 organizations
Page 1 / 1